GlassScriptPhysician profile
Arjan Hura
NPI 1023549169
$306,209.60
in general payments reported to CMS, 2019-2025
29 companies · $112K in 2025
The $112K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $3,102 · 2021: $4,661 · 2022: $46K · 2023: $38K · 2024: $102K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $164K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Travel and Lodging: $29K · Food and Beverage: $20K · Honoraria: $1,532 · Long Term Medical Supply Or Device Loan: $62.95 · Gift: $36.07 · Education: $5.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $163,985.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,175.00 |
| Travel and Lodging | $29,221.06 |
| Food and Beverage | $19,950.47 |
| Honoraria | $1,532.44 |
| Long Term Medical Supply Or Device Loan | $62.95 |
| Gift | $36.07 |
| Education | $5.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $212,024.61 | 2019-2025 | Acrysof Iq Panoptix Uv Iol, Hydrus Microstent, Clareon |
| Alcon Research LLC | $30,050.00 | 2022-2025 | Acrysof Iq Panoptix Uv Iol, Clareon, Acrysof Iq Vivity |
| Carl Zeiss Meditec, INC. | $13,762.60 | 2021-2025 | Quatera 700, Cirrus Hd-Oct, Visumax |
| Tarsus Pharmaceuticals, INC. | $12,582.74 | 2024-2025 | Xdemvy |
| Lensar, INC. | $11,937.91 | 2023-2025 | Lensar Laser System |
| Carl Zeiss Meditec USA, INC. | $6,544.63 | 2021-2025 | Visumax, Mel 90, Iolmaster 700 |
| Glaukos Corporation | $5,380.04 | 2021-2025 | Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Iaccess Precision Blade, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $3,630.43 | 2020-2025 | Tecnis Simplicity, Tecnis Iol, Axert |
| Rayner Intraocular Lenses Limited | $2,783.78 | 2022-2025 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Abbvie INC. | $2,019.31 | 2022-2023 | |
| Optos, INC. | $1,500.00 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope |
| Bausch & Lomb Americas INC. | $1,282.06 | 2024-2025 | Envista Envy Iol, Stellaris, Envista Mx60 Iol |
| Beaver-Visitec International, INC. | $709.39 | 2022-2025 | |
| Harrow Eye, LLC | $607.66 | 2024-2025 | Vevye |
| Rxsight INC | $432.72 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $254.66 | 2019-2021 | |
| Nova Eye, INC. | $150.78 | 2024-2025 | |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
| Mallinckrodt Enterprises LLC | $104.38 | 2019 | |
| Oyster Point Pharma, INC. | $83.77 | 2022 | |
| Allergan, INC. | $46.28 | 2021 | |
| Novartis Pharmaceuticals Corporation | $41.58 | 2022 | |
| Sight Sciences, INC. | $39.50 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.90 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $17.67 | 2020 | |
| Eyevance Pharmaceuticals LLC | $17.19 | 2022 | |
| Dompe US, INC. | $16.78 | 2024 | Oxervate |
| Biotissue Holdings INC. | $16.54 | 2025 | |
| Sun Pharmaceutical Industries INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9.05 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjan Hura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.